Details for 2017793380
Up to date per 01.04.2026
Actions
Details for 2017793380
Granted/Registered
European Patent
13.03.2019 A
03.07.2024 B1
04.05.2016
US
201662331827 P
19.05.2016
US
201662338869 P
07.11.2016
US
201662418774 P
08.11.2016
US
201662419237 P
14.12.2016
US
201662434404 P
02.03.2017
US
201762466358 P
01.05.2017
US
201762492758 P
A61K 31/519 20060101AFI20191119BHEP
Owner
Sun Pharmaceutical Industries, Inc.2 Independence Way Princeton, NJ 08540US
Representative
Representative
Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT
Inventor
WAGNER, Amanda, T.c/o CoNCERT Pharmaceuticals, Inc. 65 Hayden Avenue Suite 3000N Lexington MA 02421US
CASSELLA, James, V.c/o CoNCERT Pharmaceuticals, Inc. 65 Hayden Avenue Suite 3000N Lexington MA 02421US
GRAHAM, Philip, B.c/o CoNCERT Pharmaceuticals, Inc. 65 Hayden Avenue Suite 3000N Lexington MA 02421US
BRAMAN, Virginiac/o CoNCERT Pharmaceuticals, Inc. 65 Hayden Avenue Suite 3000N Lexington MA 02421US
UTTAMSINGH, Vinitac/o CoNCERT Pharmaceuticals, Inc. 65 Hayden Avenue Suite 3000N Lexington MA 02421US
VON HEHN, Janac/o CoNCERT Pharmaceuticals, Inc. 65 Hayden Avenue Suite 3000N Lexington MA 02421US
HAMILTON, Colleen, E.c/o CoNCERT Pharmaceuticals, Inc. 65 Hayden Avenue Suite 3000N Lexington MA 02421US
Information about Fees